Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria

被引：11

作者：

Isom, Robert ^{[1
]}

Shoor, Stanford ^{[2
]}

Higgins, John ^{[3
]}

Cara-Fuentes, Gabriel ^{[4
]}

Johnson, Richard J. ^{[5
]}

机构：

[1] Stanford Univ, Div Nephrol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA

[2] Stanford Univ, Div Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA

[3] Stanford Univ, Pathol, Med Ctr, Stanford, CA 94305 USA

[4] Univ Michigan, Div Pediat Nephrol, Ann Arbor, MI 48109 USA

[5] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA

来源：

KIDNEY INTERNATIONAL REPORTS | 2019年 / 4卷 / 09期

关键词：

B7-1;

D O I：

10.1016/j.ekir.2019.05.1155

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1349 / 1353

页数：5

共 8 条

[1] Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome [J].

Bhatia, Divya ;

Sinha, Aditi ;

Hari, Pankaj ;

Sopory, Shailaja ;

Saini, Savita ;

Puraswani, Mamta ;

Saini, Himanshi ;

Mitra, Dipendra K. ;

Bagga, Arvind .

PEDIATRIC RESEARCH, 2018, 84 (04) :520-526

[2]

Cara-Fuentes G, 2014, PEDIATR NEPHROL, V29, P1363, DOI 10.1007/s00467-013-2679-1

[3] Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept [J].

Dado, David ;

Parikh, Samir ;

Ayoub, Isabelle ;

Rovin, Brad ;

Nadasdy, Tibor ;

Hebert, Lee .

CLINICAL NEPHROLOGY, 2018, 89 (05) :376-380

[4] B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS [J].

Delville, Marianne ;

Baye, Emilie ;

Durrbach, Antoine ;

Audard, Vincent ;

Kofman, Tomek ;

Braun, Laura ;

Olagne, Jerome ;

Nguyen, Clement ;

Deschenes, Georges ;

Moulin, Bruno ;

Delahousse, Michel ;

Kesler-Roussey, Gwenaelle ;

Beaudreuil, Severine ;

Martinez, Frank ;

Rabant, Marion ;

Grimbert, Philippe ;

Gallazzini, Morgan ;

Terzi, Fabiola ;

Legendre, Christophe ;

Canaud, Guillaume .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (08) :2520-2527

[5] Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis [J].

Garin, Eduardo H. ;

Reiser, Jochen ;

Cara-Fuentes, Gabriel ;

Wei, Changli ;

Matar, Dany ;

Wang, Heiman ;

Alachkar, Nada ;

Johnson, Richard J. .

PEDIATRIC NEPHROLOGY, 2015, 30 (03) :469-477

[6] Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome [J].

Ling, Chen ;

Liu, Xiaorong ;

Shen, Ying ;

Chen, Zhi ;

Fan, Jianfeng ;

Jiang, Yeping ;

Meng, Qun .

PEDIATRIC NEPHROLOGY, 2018, 33 (07) :1183-1187

[7] Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? [J].

Novelli, Rubina ;

Gagliardini, Elena ;

Ruggiero, Barbara ;

Benigni, Ariela ;

Remuzzi, Giuseppe .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (05) :F335-F341

[8] Abatacept in B7-1-Positive Proteinuric Kidney Disease [J].

Yu, Chih-Chuan ;

Fornoni, Alessia ;

Weins, Astrid ;

Hakroush, Samy ;

Maiguel, Dony ;

Sageshima, Junichiro ;

Chen, Linda ;

Ciancio, Gaetano ;

Faridi, Mohd Hafeez ;

Behr, Daniel ;

Campbell, Kirk N. ;

Chang, Jer-Ming ;

Chen, Hung-Chun ;

Oh, Jun ;

Faul, Christian ;

Arnaout, M. Amin ;

Fiorina, Paolo ;

Gupta, Vineet ;

Greka, Anna ;

Burke, George W., III ;

Mundel, Peter .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2416-2423

← 1 →